Non-small Cell Lung Cancer Drug Market in South Korea

Non-small Cell Lung Cancer Drug Market in South Korea

Targeted Therapies Offer Hope in Midst of Low Survival Rates and Increasing Incidence

RELEASE DATE
12-Aug-2011
REGION
Asia Pacific
Research Code: P527-01-00-00-00
SKU: HC02348-AP-MR_08413
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02348-AP-MR_08413

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service presents an overview and analysis of the non-small cell lung cancer drug market in South Korea from 2010 to 2017. It provides an analysis of the patient load, typical treatment regimens, clinical trial statistics by phase, and treatment challenges. Along with this coverage, the research service also outlines market drivers and restraints, Market Engineering measurements, and market trends. The research service ends with a market analysis, which includes the competitive structure, and industry megatrends.

Table of Contents

Analysis of the Non-small Cell Lung Cancer Drug Market

  • Non-small Cell Lung Cancer Drug Market Analysis
Related Research
This research service presents an overview and analysis of the non-small cell lung cancer drug market in South Korea from 2010 to 2017. It provides an analysis of the patient load, typical treatment regimens, clinical trial statistics by phase, and treatment challenges. Along with this coverage, the research service also outlines market drivers and restraints, Market Engineering measurements, and market trends. The research service ends with a market analysis, which includes the competitive structure, and industry megatrends.
More Information
No Index No
Podcast No
Author Neha Koul
Industries Healthcare
WIP Number P527-01-00-00-00
Is Prebook No